Muscarinic Receptor Allosteric Modulators, University of Toledo, 23rd Apr
Summary
The University of Toledo has published patent application US20260109674A1 covering allosteric modulators of muscarinic receptors and methods of making and using the same, filed on October 23, 2023. The application names six inventors: William S. Messer Jr., Hazel Cunningham, Corey Widman, John Ellis, Isaac Schiefer, and Gina Kaup. This publication makes the technical disclosure publicly available, establishing priority date without granting enforceable rights until and unless the application issues as a granted patent.
“Allosteric modulators of muscarinic receptors, and methods of making and using the same, are described.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 223 changes logged to date.
What changed
The University of Toledo has published patent application US20260109674A1 titled 'Allosteric Modulation of Muscarinic Acetylcholine Receptor Efficacy,' covering allosteric modulators of muscarinic receptors and methods of making and using the same. The application was filed on October 23, 2023 and lists six inventors: William S. Messer Jr., Hazel Cunningham, Corey Widman, John Ellis, Isaac Schiefer, and Gina Kaup.
For pharmaceutical and biotechnology companies, this publication establishes a public record of the University of Toledo's claimed subject matter. Competitors developing allosteric modulators of muscarinic receptors should review this publication for potential freedom-to-operate concerns and assess whether their own R&D programs may overlap with the disclosed claims. This is a published application, not a granted patent — enforceable rights will only arise upon issuance of a granted patent following examination.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ALLOSTERIC MODULATION OF MUSCARINIC ACETYLCHOLINE RECEPTOR EFFICACY
Application US20260109674A1 Kind: A1 Apr 23, 2026
Assignee
The University of Toledo
Inventors
William S. Messer, JR., Hazel Cunningham, Corey Widman, John Ellis, Isaac Schiefer, Gina Kaup
Abstract
Allosteric modulators of muscarinic receptors, and methods of making and using the same, are described.
CPC Classifications
C07D 215/56 A61K 31/343 A61K 31/403 A61K 31/47 A61P 25/14 C07D 209/38 C07D 307/80
Filing Date
2023-10-23
Application No.
19117060
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.